Michael Chernew

Ahead of the final 2027 Medicare Physician Fee Schedule, guest interviewer Cameron Sabat, a medical student at Georgetown University, sat down separately with the four health policy experts that you just heard.

Dr. Michael Chernew of Harvard Medical School, a former chair of the Medicare Payment Advisory Commission or MedPAC, Dr. Jonathan Ketcham of Arizona State University, Dr. Miranda Yaver of the University of Pittsburgh, and Dr. David Meltzer of the University of Chicago.

Medical Economics Senior Editor Richard Payerton connects those interviews to cover whether the 2027 drop in the conversion factor is really a cut, what a proposed pay cut for visits on the same day as a procedure would mean for older patients, and which payment model, if any, gets it right.

And if you're listening on the morning that this episode comes out, Thursday, October 29th, there's still time to join us this afternoon for Physicians Practice Practice Academy series.

The 2027 Medicare Physician Fee Schedule is highly anticipated and will be influential across U.S. healthcare.

It most likely won't settle the debate about how physicians should be paid and how much.

Michael Chernew is Harvard Professor of Healthcare Policy and former chair of MEDPAC, the Medicare Payment Advisory Commission.

You know, you've spent decades studying how we pay for healthcare.

We just had a briefing on Capitol Hill.

We had, uh, Michael Chernew, the former MedPAC chair, we had John Brooks, one of the, um, directors at CMS, and we had ...

I, I mean, I was so impressed, I mean, filled with, with Hill staffers in there trying to better understand Medicare Advantage.

Because I think most people do think that it is the, it is, it needs to succeed, it needs to, to continue, and it is, overall, a very successful public-private partnership.